首页|白芍总苷胶囊联合甲氨蝶呤片治疗类风湿关节炎的临床研究

白芍总苷胶囊联合甲氨蝶呤片治疗类风湿关节炎的临床研究

扫码查看
目的 观察白芍总苷胶囊联合甲氨蝶呤片治疗类风湿关节炎(RA)的临床疗效.方法 选取2021 年9 月至2022 年9 月收治的56 例RA患者作为研究对象,按照随机数字表法分为2 组,对照组28 例予甲氨蝶呤片治疗,治疗组28 例在对照组的基础上联合白芍总苷胶囊治疗.2 组均治疗3 个月.比较2 组治疗前后临床症状(包括晨僵时间、关节疼痛、关节肿胀及握力)及红细胞沉降率(ESR)、类风湿因子(RF)和C反应蛋白(CRP)水平变化情况,比较 2 组治疗后病情活动度、病情缓解及骨破坏发生情况.结果 与本组治疗前比较,2 组治疗后晨僵时间均缩短(P<0.05),关节疼痛评分及关节肿胀评分均降低(P<0.05),握力水平均升高(P<0.05),且治疗组治疗后晨僵时间、关节疼痛、关节肿胀及握力水平改善均优于对照组(P<0.05).与本组治疗前比较,2 组治疗后ESR、RF及CRP水平均降低(P<0.05),且治疗组治疗后ESR、RF及CRP水平均低于对照组(P<0.05).治疗组治疗后病情处于稳定期占比71.43%(20/28),对照组稳定期占比14.29%(4/28),治疗组治疗后病情处于稳定期占比高于对照组(P<0.05).治疗组治疗后病情总缓解率92.86%(26/28),对照组治疗后病情总缓解率71.43%(20/28),治疗组病情总缓解率高于对照组(P<0.05).治疗组治疗后骨破坏总检出率7.14%(2/28),对照组总检出率 39.28%(11/28),治疗组骨破坏总检出率低于对照组(P<0.05).结论 白芍总苷胶囊联合甲氨蝶呤片治疗RA疗效确切,可有效改善患者临床症状,减轻炎症反应,抑制病情活动,促进病情缓解,预防骨破坏的发生.
Clinical efficacy of total paeoniflorin capsules combined with methotrexate on rheumatoid arthritis
Objective To observe the clinical efficacy of total paeoniflorin capsules combined with methotrexate on rheu-matoid arthritis(RA).Methods From September 2021 to September 2022,a total of 56 RA patients were randomly assigned into the treatment group(n =28)and the control group(n =28).All patients were managed by methotrexate,and those in the treatment group were additionally treated with total paeoniflorin capsules.Treated for 3 months,the aim was to compare clinical symptoms(duration of morning stiffness,articular pain,joint swelling and pain,grip strength),biochemical indicators(erythro-cyte sedimentation rate[ESR],rheumatoid factor[RF],C-reactive protein[CRP]),disease activity,disease remission rate,bone destruction.The curative effect was assessed.Results After treatment,significantly shorter duration of morning stiff-ness,decreased articular pain scores,decreased joint swelling and pain scores,increased grip strength were found in the two groups than those before treatment(all P<0.05),improvement of which in the treatment group were significantly better(all P<0.05).After treatment,ESR,RF and CRP in the both groups were significantly decreased(P<0.05),which decreased notably in the treatment group compared with the control group(P<0.05).The proportion of stable stage of illness in the treat-ment group was significantly higher than that in the control group(71.43%[20/28]vs 14.29%[4/28],[P<0.05],respec-tively).The total remission rate of the disease was 92.85%(26/28)in the treatment group,significantly higher than that of 71.43%(20/28)in the control group(P<0.05).The total detection rate of bone destruction in the treatment group was signif-icantly lower than that in the control group(7.14%[2/28]vs 39.28%[11/28],[P<0.05],respectively).Conclusion For RA patients,total paeoniflorin capsules combined with metho-trexate has definite curative effect,which can effectively improve clinical symptoms,reduce inflammation,inhibit disease activity,promote disease remission and prevent bone destruction.

Rheumatoid arthritisPaeonia glycosidesMethotrexateIntegrated traditional Chinese and Western medi-cine therapy

皮天龙、刘红杰

展开 >

河北省张家口市第二医院康复医学科,河北 张家口 075000

类风湿关节炎 白芍总苷 甲氨蝶呤 中西医结合疗法

河北省中医药管理局2022年度中医药类科研计划项目

2022530

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(1)
  • 2
  • 19